FdaApplication
ANDA 209696
Identifiers
- fda_app_no: ANDA209696
Properties
| Property | Value |
|---|---|
| applicant_name | ADAPTIS |
| application_type | ANDA |
| approval_date | 2018-05-03 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET;ORAL |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET;ORAL |
5 products